Three-year follow-up study reveals improved survival rate in NSCLC patients underwent guideline-concordant diagnosis and treatment
Article in Frontiers in Oncology (May 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
A phase IV study to evaluate the safety of fruquintinib in Chinese patients in real-world clinical practice
Article in The Oncologist (April 2024)
Between-hospital variation in indicators of quality of care: a systematic review
Article in BMJ Quality & Safety (February 2024)